These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1855995)

  • 41. Biological activity of Borrelia burgdorferi antigens.
    Benach JL; Coleman JL; Garcia-Monco JC; Deponte PC
    Ann N Y Acad Sci; 1988; 539():115-25. PubMed ID: 2461134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunological characterization of a low molecular mass polypeptidic antigen of Borrelia burgdorferi.
    Sambri V; Moroni A; Massaria F; Brocchi E; De Simone F; Cevenini R
    FEMS Microbiol Immunol; 1991 Nov; 3(6):345-9. PubMed ID: 1725956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specific immunofluorescent staining of pathogenic treponemes with a monoclonal antibody.
    Ito F; Hunter EF; George RW; Pope V; Larsen SA
    J Clin Microbiol; 1992 Apr; 30(4):831-8. PubMed ID: 1374079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of a tick isolate of Borrelia burgdorferi that possesses a major low-molecular-weight surface protein.
    Kurashige S; Bissett M; Oshiro L
    J Clin Microbiol; 1990 Jun; 28(6):1362-6. PubMed ID: 2199499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies.
    Barbour AG; Bundoc V
    Infect Immun; 2001 Feb; 69(2):1009-15. PubMed ID: 11159997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1 wild-type and an OspC-lacking FEM1 variant.
    Kraiczy P; Hunfeld KP; Peters S; Würzner R; Acker G; Wilske B; Brade V
    J Med Microbiol; 2000 Oct; 49(10):917-928. PubMed ID: 11023189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Borrelia burgdorferi-specific monoclonal antibodies derived from mice primed with Lyme disease spirochete-infected Ixodes scapularis ticks.
    Mbow ML; Gilmore RD; Stevenson B; Golde WT; Piesman J; Johnson BJ
    Hybrid Hybridomics; 2002 Jun; 21(3):179-82. PubMed ID: 12165143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato.
    Wilske B; Fingerle V; Preac-Mursic V; Jauris-Heipke S; Hofmann A; Loy H; Pfister HW; Rössler D; Soutschek E
    Med Microbiol Immunol; 1994 Feb; 183(1):43-59. PubMed ID: 8202030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterogeneity of outer membrane proteins in Borrelia burgdorferi: comparison of osp operons of three isolates of different geographic origins.
    Jonsson M; Noppa L; Barbour AG; Bergström S
    Infect Immun; 1992 May; 60(5):1845-53. PubMed ID: 1563773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of VspB of Borrelia turicatae, a major outer membrane protein expressed in blood and tissues of mice.
    Pennington PM; Cadavid D; Barbour AG
    Infect Immun; 1999 Sep; 67(9):4637-45. PubMed ID: 10456910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The western black-legged tick, Ixodes pacificus: a vector of Borrelia burgdorferi.
    Burgdorfer W; Lane RS; Barbour AG; Gresbrink RA; Anderson JR
    Am J Trop Med Hyg; 1985 Sep; 34(5):925-30. PubMed ID: 3898886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An OspC-specific monoclonal antibody passively protects mice from tick-transmitted infection by Borrelia burgdorferi B31.
    Mbow ML; Gilmore RD; Titus RG
    Infect Immun; 1999 Oct; 67(10):5470-2. PubMed ID: 10496931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Limited surface exposure of Borrelia burgdorferi outer surface lipoproteins.
    Cox DL; Akins DR; Bourell KW; Lahdenne P; Norgard MV; Radolf JD
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7973-8. PubMed ID: 8755587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Borrelia burgdorferi mutant lacking Osp: biological and immunological characterization.
    Sadziene A; Thomas DD; Barbour AG
    Infect Immun; 1995 Apr; 63(4):1573-80. PubMed ID: 7890424
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates.
    Parveen N; Fernandez MC; Haynes AM; Zhang RL; Godornes BC; Centurion-Lara A; Giacani L
    Vaccine; 2019 Mar; 37(13):1807-1818. PubMed ID: 30797635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice.
    Bockenstedt LK; Hodzic E; Feng S; Bourrel KW; de Silva A; Montgomery RR; Fikrig E; Radolf JD; Barthold SW
    Infect Immun; 1997 Nov; 65(11):4661-7. PubMed ID: 9353047
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of monoclonal antibodies to identify outer membrane antigens of Actinobacillus species.
    Healey MC; Gharpure HM; Kleinschuster SJ; Hwang HH; Johnston AV
    Am J Vet Res; 1986 Jul; 47(7):1446-51. PubMed ID: 3526999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aspects of the diagnosis of Lyme borreliosis.
    Karlsson M
    Scand J Infect Dis Suppl; 1990; 67():1-59. PubMed ID: 2371553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sequence analysis and characterization of a 40-kilodalton Borrelia hermsii glycerophosphodiester phosphodiesterase homolog.
    Shang ES; Skare JT; Erdjument-Bromage H; Blanco DR; Tempst P; Miller JN; Lovett MA
    J Bacteriol; 1997 Apr; 179(7):2238-46. PubMed ID: 9079909
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complement-mediated in vitro bactericidal activity of monoclonal antibodies reactive with outer-surface-protein OspB of Borrelia burgdorferi.
    Cevenini R; Sambri V; Massaria F; La Placa M; Brocchi E; De Simone F
    FEMS Microbiol Lett; 1992 Jan; 69(2):147-52. PubMed ID: 1537543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.